Novo Nordisk A/S
NONOF
$49.68
$0.160.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.16% | 18.66% | 21.48% | 22.67% | 24.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.16% | 18.66% | 21.48% | 22.67% | 24.86% |
| Cost of Revenue | 30.58% | 29.95% | 25.09% | 24.10% | 23.21% |
| Gross Profit | 7.73% | 16.64% | 20.83% | 22.41% | 25.16% |
| SG&A Expenses | 5.31% | 9.97% | 14.38% | 9.26% | 9.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -115.17% | 751.03% | 245.50% | -144.33% | 219.00% |
| Total Operating Expenses | 20.72% | 15.10% | 15.10% | 12.96% | 14.21% |
| Operating Income | 1.51% | 22.73% | 28.90% | 34.21% | 37.85% |
| Income Before Tax | 6.72% | 12.03% | 25.18% | 16.90% | 21.44% |
| Income Tax Expenses | 11.53% | 16.21% | 29.54% | 21.18% | 24.76% |
| Earnings from Continuing Operations | 5.48% | 10.95% | 24.06% | 15.82% | 20.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.48% | 10.95% | 24.06% | 15.82% | 20.61% |
| EBIT | 1.51% | 22.73% | 28.90% | 34.21% | 37.85% |
| EBITDA | 5.63% | 24.78% | 29.06% | 31.85% | 34.24% |
| EPS Basic | 5.74% | 11.32% | 24.60% | 16.43% | 21.37% |
| Normalized Basic EPS | 4.78% | 21.92% | 26.32% | 29.54% | 35.01% |
| EPS Diluted | 5.85% | 11.45% | 24.77% | 16.56% | 21.47% |
| Normalized Diluted EPS | 4.88% | 22.04% | 26.43% | 29.64% | 35.11% |
| Average Basic Shares Outstanding | -0.26% | -0.35% | -0.43% | -0.54% | -0.64% |
| Average Diluted Shares Outstanding | -0.35% | -0.44% | -0.52% | -0.62% | -0.72% |
| Dividend Per Share | 10.74% | 18.93% | 18.93% | 19.95% | 19.95% |
| Payout Ratio | 0.11% | 0.06% | -0.04% | 0.03% | 0.16% |